marijuana stocks

Form 8-K for VERDE SCIENCE, INC.


27-May-2015

Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain OfficersOn May 19, 2015, the Board of Directors elected Bradley J. Dixon and John Percival to two vacant seats on the Company’s Board of Directors.

Bradley J. Dixon, J.D. – Director

Mr. Dixon, 40, is an attorney and partner in the Boise, Idaho office of Stoel Rives, LLP, which has locations throughout the northwest and California. He was selected as a director because the Board believes his litigation experience, which includes Agricultural, Natural Resources, Labor and Employment, and Product Liability cases. Mr. Dixon’s trial experience representing clients through complex litigation on a broad range of disputes including complex commercial litigation, employment, insurance coverage, products liability, title insurance, foreclosure and bankruptcy trial practice, as well his governmental affairs service experience meshes well with the future needs of Verde Science. With his broad legal background he can help guide Verde through the challenges of this business as it matures and spreads to more and more jurisdictions.

John Percival – Director

Mr. Percival, 71, is a Director and Managing Director of various companies in Australia. His career started as a stockbroker with a securities firm, Daysh Renouf & Co. in New Zealand, where he was trained in share market dealings, company listings and financings. After the 1969 Poseidon Nickel Boom in the Australian resource sector of the stock market, the company partners sent John to Australia to research and work in the mining sector. Upon his return to New Zealand in 1972, he took a position as Investment Manager with NZ United Corporation, a merchant bank, which later became Barclays Bank New Zealand Limited. At Barclays, he rose to the position of General Manager Investments, and he advised and managed over $500,000,000 of superannuation and private funds. When Barclays closed its New Zealand office in 1988, John returned to Australia where he worked in finance and securities for the State Bank of New South Wales. He was selected as a Director because of his over 50 years experience in the financial markets.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$GWPH Continues To Rally: A Technical Look

GW Pharmaceuticals Continues To Rally: A Technical Look GW Pharmaceuticals Plc (NASDAQ:GWPH)…

$OXIS CEO Tells Shareholders Biotech Company Making ‘Substantial Progress

Oxis Chairman And CEO Tells Shareholders Biotech Company Making ‘Substantial Progress’ With…

Tilray Brands, Inc. (TLRY) Receives Verification From the Natural Health Science Foundation

Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia…

TILT Holdings Inc. (TLLTF) Announces Exclusive Partnership with Social Impact Driven Brand

TILT Holdings Announces Exclusive Partnership with Social Impact Driven Brand, Black Buddha…